Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Pulmonary Hypertension

  Free Subscription


Articles published in J Heart Lung Transplant

Retrieve available abstracts of 106 articles:
HTML format



Single Articles


    August 2021
  1. DE PERROT M, Gopalan D, Jenkins D, Lang IM, et al
    Evaluation and management of patients with chronic thromboembolic pulmonary hypertension - consensus statement from the ISHLT.
    J Heart Lung Transplant. 2021 Aug 3. pii: S1053-2498(21)02440.
    PubMed     Abstract available


    July 2021
  2. BENZA RL, Ghofrani HA, Grunig E, Hoeper MM, et al
    Effect of riociguat on right ventricular function in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
    J Heart Lung Transplant. 2021 Jul 10. pii: S1053-2498(21)02399.
    PubMed     Abstract available


    May 2021
  3. DAURIAT G, Reynaud-Gaubert M, Cottin V, Lamia B, et al
    Severe pulmonary hypertension associated with chronic obstructive pulmonary disease: A prospective French multicenter cohort.
    J Heart Lung Transplant. 2021 May 11. pii: S1053-2498(21)02307.
    PubMed     Abstract available


  4. OLSSON KM, Kamp JC, Hoeper MM
    Pregnancy in PAH: Reality is changing.
    J Heart Lung Transplant. 2021;40:395-396.
    PubMed    


    April 2021
  5. ARTHUR ATAAM J, Mercier O, Lamrani L, Amsallem M, et al
    Retraction notice to ICAM-1 PROMOTES THE ABNORMAL ENDOTHELIAL CELL PHENOTYPE IN CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION.
    J Heart Lung Transplant. 2021;40:318.
    PubMed     Abstract available


    March 2021
  6. GIRGIS RE, Hoeper MM
    Pulmonary hypertension in fibrosing idiopathic interstitial pneumonia: Uncertainties, challenges and opportunities.
    J Heart Lung Transplant. 2021 Mar 5. pii: S1053-2498(21)02221.
    PubMed     Abstract available


  7. TOBITA K, Goda A, Nishida Y, Takeuchi K, et al
    Factors contributing to exercise capacity in chronic thromboembolic pulmonary hypertension with near-normal hemodynamics.
    J Heart Lung Transplant. 2021 Mar 5. pii: S1053-2498(21)02222.
    PubMed     Abstract available


  8. WESLEY MILKS M, Sahay S, Benza RL, Farber HW, et al
    Risk assessment in patients with pulmonary arterial hypertension in the era of COVID 19 pandemic and the telehealth revolution: State of the art review.
    J Heart Lung Transplant. 2021;40:172-182.
    PubMed     Abstract available


    February 2021
  9. BRAAMS NJ, van Leeuwen JW, Vonk Noordegraaf A, Nossent EJ, et al
    Right ventricular adaptation to pressure-overload: Differences between chronic thromboembolic pulmonary hypertension and idiopathic pulmonary arterial hypertension.
    J Heart Lung Transplant. 2021 Feb 28. pii: S1053-2498(21)02216.
    PubMed     Abstract available


  10. NATHAN SD, Cottin V, Behr J, Hoeper MM, et al
    Impact of lung morphology on clinical outcomes with riociguat in patients with pulmonary hypertension and idiopathic interstitial pneumonia: A post hoc subgroup analysis of the RISE-IIP study.
    J Heart Lung Transplant. 2021 Feb 19. pii: S1053-2498(21)02178.
    PubMed     Abstract available


  11. HOEPER MM, Held M
    Response to Badagliacca et al: Multi-dimensional assessment and cluster analysis for idiopathic pulmonary arterial hypertension phenotyping.
    J Heart Lung Transplant. 2021;40:167-168.
    PubMed    


  12. BADAGLIACCA R, Papa S, Rischard F
    Multidimensional assessment and cluster analysis for idiopathic pulmonary arterial hypertension phenotyping.
    J Heart Lung Transplant. 2021;40:166-167.
    PubMed    


    November 2020
  13. BESHAY S, Sahay S
    Risk stratification in pulmonary hypertension associated with interstitial lung disease: The holy grail?
    J Heart Lung Transplant. 2020 Nov 27. pii: S1053-2498(20)31850.
    PubMed    


  14. JONE PN, Duchateau N, Pan Z, Ivy DD, et al
    Right ventricular area strain from 3-dimensional echocardiography: Mechanistic insight of right ventricular dysfunction in pediatric pulmonary hypertension.
    J Heart Lung Transplant. 2020 Nov 15. pii: S1053-2498(20)31831.
    PubMed     Abstract available


    October 2020
  15. PEREZ-VIZCAINO F
    Lung ACE2 and ADAM17 in pulmonary arterial hypertension: Implications for COVID-19?
    J Heart Lung Transplant. 2020;39:1167-1169.
    PubMed    


    August 2020
  16. RANGANATH NK, Smith DE, Kon ZN
    Awareness of bias in lung transplant registry analyses.
    J Heart Lung Transplant. 2020;39:850-851.
    PubMed    


    July 2020
  17. BADAGLIACCA R, Sciomer S, Petrosillo N
    Endothelin receptor antagonists for pulmonary arterial hypertension and COVID-19: Friend or foe?
    J Heart Lung Transplant. 2020;39:729-730.
    PubMed    


    June 2020
  18. YOGESWARAN A, Tello K, Faber M, Sommer N, et al
    Risk assessment in severe pulmonary hypertension due to interstitial lung disease.
    J Heart Lung Transplant. 2020 Jun 25. pii: S1053-2498(20)31615.
    PubMed     Abstract available


  19. ROAN JN, Hsu CH, Fang SY, Chiu MS, et al
    ProT-alpha gene transfer attenuates cardiopulmonary remedying and mortality in a flow-induced pulmonary hypertension rat model.
    J Heart Lung Transplant. 2020 Jun 6. pii: S1053-2498(20)31580.
    PubMed     Abstract available


    May 2020
  20. DESJARDIN JT, Kolaitis NA, Kime N, Kronmal RA, et al
    Age-related differences in hemodynamics and functional status in pulmonary arterial hypertension: Baseline results from the Pulmonary Hypertension Association Registry.
    J Heart Lung Transplant. 2020 May 16. pii: S1053-2498(20)31557.
    PubMed     Abstract available


  21. PRESTON IR, Burger CD, Bartolome S, Safdar Z, et al
    Ambrisentan in portopulmonary hypertension: A multicenter, open-label trial.
    J Heart Lung Transplant. 2020;39:464-472.
    PubMed     Abstract available


    April 2020
  22. DAS BB, Jadotte MM, Chan KC
    Use of selexipag in a child with pulmonary hypertension associated with sickle cell disease.
    J Heart Lung Transplant. 2020 Apr 29. pii: S1053-2498(20)31535.
    PubMed    


  23. KWON JM, Kim KH, Medina-Inojosa J, Jeon KH, et al
    Artificial intelligence for early prediction of pulmonary hypertension using electrocardiography.
    J Heart Lung Transplant. 2020 Apr 23. pii: S1053-2498(20)31516.
    PubMed     Abstract available


  24. CHOMETTE L, Caravita S, Dewachter C, Abramowicz M, et al
    Genetic Profiling of Combined Post-Capillary and Pre-Capillary Pulmonary Hypertension in Left Heart Diseases.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  25. ROTHAS J, Mahoney E
    Pulmonary Hypertension Support Group: A Year in Review.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  26. BULLOCK J, Chau P, Wood L, Bock MJ, et al
    Short-Term Outcomes of Infants and Children Receiving Selexipag for Pulmonary Hypertension.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  27. DJELLAL Y, Vachiery J, Dewachter C, Roussoulieres A, et al
    Role of a Prediction Score of Heart Failure with Left Ventricular Preserved Ejection Fraction in the Differential Diagnosis of Pulmonary Hypertension.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  28. ALBULUSHI A, Dhar K, Stoller D, Hyden M, et al
    The Effect of Exercise on Endothelin 1 Level in Patients with Pulmonary Hypertension.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  29. GOLTS EM, Aoki KC, Afshar K, Bigbee JM, et al
    Tricuspid Surgery and Pulmonary Thromboendarterectomy in Patients with Chronic Thromboembolic Pulmonary Hypertension.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  30. KULARATNE M, Weatherald J, Varughese R, Helmersen D, et al
    Validation of a Nurse Led Triage Algorithm for New Referrals in a Specialized Pulmonary Hypertension Clinic.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  31. BOULATE D, Pavec JL, Kriens M, Mussot S, et al
    Switching from Heart-Lung to Double Lung Transplantations in Patients with Pre-Capillary Pulmonary Hypertension: A Monocentric Experience.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  32. KEARNEY K, Bart N, Robson D, Muthiah K, et al
    Haemodynamic Response of Pulmonary Hypertension Secondary to Left Heart Disease with Continuous Flow Left Ventricular Assist Device Therapy (CF-LVADS): Post-Transplant Outcomes.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  33. DESJARDIN JT, Svetlichnaya Y, Kolaitis NA, Singer JP, et al
    Right Ventricular Outflow Tract Doppler Envelope Notching Predicts Pulmonary Hypertension and Outcomes in Lung Transplant Candidates.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  34. ARTHUR ATAAM J, Amsallem M, Contrepois K, Guihaire J, et al
    Targeted Angiogenesis Gene Expression Profiling of Patients with Chronic Thromboembolic Pulmonary Hypertension.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  35. BOTTA L, Murana G, Fiorentino M, Marianna B, et al
    Impact of Severe Pulmonary Hypertension on Right Heart Hemodynamics and Outcomes Following Cardiac Transplantation: A Single Center Experience.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  36. GABANIC A, Smith SA
    Pulmonary Hypertension Resolves Post Transplantation in Patients Treated with Milrinone or Dobutamine.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  37. VISHNEVSKY A, Pirlamarla P, Massey HT, Goldhammer J, et al
    Severe Pulmonary Hypertension in the Setting of Complex Structural Heart Disease.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  38. BENTLEY RF, Barker M, Esfandiari S, Wright SP, et al
    The Relationship between Pulmonary Artery Pulse Pressure and Pulmonary Artery Wedge Pressure during Exercise in Health and in Patients with Suspected Pulmonary Hypertension.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  39. BART NK, Ambati C, Kearney K, Scheuer S, et al
    Outcomes of Patients with Chronic Thromboembolic Pulmonary Hypertension Risk Stratified by a Dedicated Heart Team to Receive Pulmonary Endarectomy or Balloon Pulmonary Angiogiplasty.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  40. WANG W, Wilson C, Collum S, Bi W, et al
    Beta Adrenoceptor Ligands for the Treatment of Group 3 Pulmonary Hypertension and Cor Pulmonale: A Novel Therapeutic Target?
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  41. KWON J, Kim K
    Artificial Intelligence for Early Prediction of Pulmonary Hypertension Using Electrocardiography.
    J Heart Lung Transplant. 2020;39.
    PubMed     Abstract available


  42. KANWAR MK
    Biomarkers in pulmonary arterial hypertension: Moving closer toward precision medicine?
    J Heart Lung Transplant. 2020;39:287-288.
    PubMed    


  43. BADAGLIACCA R, Rischard F, Papa S, Kubba S, et al
    Clinical implications of idiopathic pulmonary arterial hypertension phenotypes defined by cluster analysis.
    J Heart Lung Transplant. 2020;39:310-320.
    PubMed     Abstract available


    March 2020
  44. NASIR BS, Hartwig MG
    Secondary Pulmonary Hypertension; getting down to the nuts and BOLT. Author's reply to Ranganath et al.
    J Heart Lung Transplant. 2020 Mar 5. pii: S1053-2498(20)31424.
    PubMed    


    February 2020
  45. RUOPP NF, Maron BA
    Pulmonary arterial hypertension in the modern era: The intersection of genotype and phenotype.
    J Heart Lung Transplant. 2020;39:113-114.
    PubMed    


  46. HIRAIDE T, Kataoka M, Suzuki H, Aimi Y, et al
    Poor outcomes in carriers of the RNF213 variant (p.Arg4810Lys) with pulmonary arterial hypertension.
    J Heart Lung Transplant. 2020;39:103-112.
    PubMed     Abstract available


    January 2020
  47. SHAH M, Saeed O, Shin J, Murthy S, et al
    Predicted heart mass-based size matching among recipients with moderate pulmonary hypertension: Outcomes and sex effect.
    J Heart Lung Transplant. 2020 Jan 31. pii: S1053-2498(20)31357.
    PubMed     Abstract available


    December 2019
  48. BRAAMS NJ, Ruigrok D, Schokker MGM, Padervinskiene L, et al
    Pulmonary vascular imaging characteristics after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension.
    J Heart Lung Transplant. 2019 Dec 5. pii: S1053-2498(19)31791.
    PubMed     Abstract available


    September 2019
  49. ROSENZWEIG EB, Gannon WD, Madahar P, Agerstrand C, et al
    Extracorporeal life support bridge for pulmonary hypertension: A high-volume single-center experience.
    J Heart Lung Transplant. 2019 Sep 12. pii: S1053-2498(19)31671.
    PubMed     Abstract available


  50. NASIR BS, Mulvihill MS, Barac YD, Bishawi M, et al
    Single lung transplantation in patients with severe secondary pulmonary hypertension.
    J Heart Lung Transplant. 2019;38:939-948.
    PubMed     Abstract available


  51. HANSMANN G, Koestenberger M, Alastalo TP, Apitz C, et al
    2019 updated consensus statement on the diagnosis and treatment of pediatric pulmonary hypertension: The European Pediatric Pulmonary Vascular Disease Network (EPPVDN), endorsed by AEPC, ESPR and ISHLT.
    J Heart Lung Transplant. 2019;38:879-901.
    PubMed     Abstract available


    August 2019
  52. LIU J, Thakrar M
    Predicting survival for non-operative chronic thromboembolic pulmonary hypertension: Practice can make perfect.
    J Heart Lung Transplant. 2019;38:843-844.
    PubMed    


    June 2019
  53. ARTHUR ATAAM J, Mercier O, Lamrani L, Amsallem M, et al
    ICAM-1 promotes the abnormal endothelial cell phenotype in chronic thromboembolic pulmonary hypertension.
    J Heart Lung Transplant. 2019 Jun 19. pii: S1053-2498(19)31552.
    PubMed     Abstract available


    April 2019
  54. TANIGUCHI Y, Jais X, Jevnikar M, Boucly A, et al
    Predictors of survival in patients with not-operated chronic thromboembolic pulmonary hypertension.
    J Heart Lung Transplant. 2019 Apr 27. pii: S1053-2498(19)31474.
    PubMed     Abstract available


    March 2019
  55. ENDE-VERHAAR YM, Meijboom LJ, Kroft LJM, Beenen LFM, et al
    Usefulness of standard computed tomography pulmonary angiography performed for acute pulmonary embolism for identification of chronic thromboembolic pulmonary hypertension: results of the InShape III study.
    J Heart Lung Transplant. 2019 Mar 15. pii: S1053-2498(19)31424.
    PubMed     Abstract available


  56. BRAVOS E, Cottin V, Dauphin C, Bouvaist H, et al
    Cancer incidence in patients with pre-capillary pulmonary hypertension.
    J Heart Lung Transplant. 2019 Mar 15. pii: S1053-2498(19)31430.
    PubMed    


    February 2019
  57. HUBBARD R, Miller R, Tumin D, Tobias JD, et al
    Transplant outcomes for idiopathic pulmonary hypertension in children.
    J Heart Lung Transplant. 2019 Feb 5. pii: S1053-2498(19)31344.
    PubMed    


  58. SHAFRAN I, Lang IM
    Diffusion capacity of the lung-a disease biomarker linking ventilation and circulation.
    J Heart Lung Transplant. 2019;38:130-132.
    PubMed    


  59. AIRHART S, Verlinden N, Badie N, Raina A, et al
    Use of an implantable wireless pulmonary pressure monitor during transition of therapy in pulmonary arterial hypertension.
    J Heart Lung Transplant. 2019;38:227-230.
    PubMed    


  60. VACHIERY JL, Galie N, Barbera JA, Frost AE, et al
    Initial combination therapy with ambrisentan+tadalafil on pulmonary arterial hypertensionrelated hospitalization in the AMBITION trial.
    J Heart Lung Transplant. 2019;38:194-202.
    PubMed     Abstract available


    January 2019
  61. FROST A, Janmohamed M, Fritz JS, McConnell JW, et al
    Safety and tolerability of transition from inhaled treprostinil to oral selexipag in pulmonary arterial hypertension: Results from the TRANSIT-1 study.
    J Heart Lung Transplant. 2019;38:43-50.
    PubMed     Abstract available


    October 2018
  62. RICHTER MJ, Harutyunova S, Bollmann T, Classen S, et al
    Long-term safety and outcome of intravenous treprostinil via an implanted pump in pulmonary hypertension.
    J Heart Lung Transplant. 2018;37:1235-1244.
    PubMed     Abstract available


    September 2018
  63. ROSE L, Prins KW, Archer SL, Pritzker M, et al
    Survival in pulmonary hypertension due to chronic lung disease: Influence of low diffusion capacity of the lungs for carbon monoxide.
    J Heart Lung Transplant. 2018 Sep 14. pii: S1053-2498(18)31658.
    PubMed     Abstract available


    May 2018
  64. AMSALLEM M, Guihaire J, Arthur Ataam J, Lamrani L, et al
    Impact of the initiation of balloon pulmonary angioplasty program on referral of patients with chronic thromboembolic pulmonary hypertension to surgery.
    J Heart Lung Transplant. 2018 May 24. pii: S1053-2498(18)31478.
    PubMed     Abstract available


    April 2018
  65. SKORO-SAJER N, Gerges C, Gerges M, Panzenbock A, et al
    Usefulness of thrombosis and inflammation biomarkers in chronic thromboembolic pulmonary hypertension-sampling plasma and surgical specimens.
    J Heart Lung Transplant. 2018 Apr 25. pii: S1053-2498(18)31433.
    PubMed     Abstract available


    March 2018
  66. BENZA RL, Farber HW, Frost A, Grunig E, et al
    REVEAL risk score in patients with chronic thromboembolic pulmonary hypertension receiving riociguat.
    J Heart Lung Transplant. 2018 Mar 1. pii: S1053-2498(18)31381.
    PubMed     Abstract available


    December 2017
  67. DIAMOND JM, Ramphal K, Porteous MK, Cantu E 3rd, et al
    Association of long pentraxin-3 with pulmonary hypertension and primary graft dysfunction in lung transplant recipients.
    J Heart Lung Transplant. 2017 Dec 20. pii: S1053-2498(17)32189.
    PubMed    


  68. KRIECHBAUM SD, Wiedenroth CB, Wolter JS, Hutz R, et al
    N-terminal pro-B-type natriuretic peptide for monitoring after balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension.
    J Heart Lung Transplant. 2017 Dec 8. pii: S1053-2498(17)32145.
    PubMed     Abstract available


    July 2017
  69. LANKEIT M, Krieg V, Hobohm L, Kolmel S, et al
    Pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension.
    J Heart Lung Transplant. 2017 Jul 1. pii: S1053-2498(17)31877.
    PubMed     Abstract available


    May 2017
  70. GODINAS L, Sattler C, Lau EM, Jais X, et al
    Dead-space ventilation is linked to exercise capacity and survival in distal chronic thromboembolic pulmonary hypertension.
    J Heart Lung Transplant. 2017 May 22. pii: S1053-2498(17)31805.
    PubMed     Abstract available


  71. KANWAR MK
    Survival in pulmonary hypertension: Experiences from a referral center.
    J Heart Lung Transplant. 2017 May 15. pii: S1053-2498(17)31795.
    PubMed    


  72. GALIE N, Grimminger F, Grunig E, Hoeper MM, et al
    Comparison of hemodynamic parameters in treatment-naive and pre-treated patients with pulmonary arterial hypertension in the randomized phase III PATENT-1 study.
    J Heart Lung Transplant. 2017;36:509-519.
    PubMed     Abstract available


    April 2017
  73. HASCOET S, Baruteau AE, Humbert M, Simonneau G, et al
    Long-term outcomes of pulmonary arterial hypertension under specific drug therapy in Eisenmenger syndrome.
    J Heart Lung Transplant. 2017;36:386-398.
    PubMed     Abstract available


  74. VERBELEN T, Burkhoff D, Kasama K, Delcroix M, et al
    Systolic and diastolic unloading by mechanical support of the acute vs the chronic pressure overloaded right ventricle.
    J Heart Lung Transplant. 2017;36:457-465.
    PubMed     Abstract available


  75. VACHIERY JL, Hoeper MM, Peacock AJ, Sitbon O, et al
    Ambrisentan use for pulmonary arterial hypertension in a post-authorization drug registry: The VOLibris Tracking Study.
    J Heart Lung Transplant. 2017;36:399-406.
    PubMed     Abstract available


    February 2017
  76. GALL H, Felix JF, Schneck FK, Milger K, et al
    The Giessen Pulmonary Hypertension Registry: Survival in pulmonary hypertension subgroups.
    J Heart Lung Transplant. 2017 Feb 17. pii: S1053-2498(17)31625.
    PubMed     Abstract available


  77. DUARTE AG, Lin YL, Sharma G
    Incidence of right heart catheterization in patients initiated on pulmonary arterial hypertension therapies: A population-based study.
    J Heart Lung Transplant. 2017;36:220-226.
    PubMed     Abstract available


  78. CLAESSEN G, La Gerche A, Petit T, Gillijns H, et al
    Right ventricular and pulmonary vascular reserve in asymptomatic BMPR2 mutation carriers.
    J Heart Lung Transplant. 2017;36:148-156.
    PubMed     Abstract available


  79. CHAKINALA MM, Feldman JP, Rischard F, Mathier M, et al
    Transition from parenteral to oral treprostinil in pulmonary arterial hypertension.
    J Heart Lung Transplant. 2017;36:193-201.
    PubMed     Abstract available


    December 2016
  80. CARAVITA S, Faini A, Deboeck G, Bondue A, et al
    Pulmonary hypertension and ventilation during exercise: Role of the pre-capillary component.
    J Heart Lung Transplant. 2016 Dec 23. pii: S1053-2498(16)30471.
    PubMed     Abstract available


    August 2016
  81. MERCIER O, Arthur Ataam J, Langer NB, Dorfmuller P, et al
    Abnormal pulmonary endothelial cells may underlie the enigmatic pathogenesis of chronic thromboembolic pulmonary hypertension.
    J Heart Lung Transplant. 2016 Aug 20. pii: S1053-2498(16)30293.
    PubMed     Abstract available


    July 2016
  82. FINCH KT, Stratton EA, Farber HW
    Ranolazine for the treatment of pulmonary hypertension associated with heart failure with preserved ejection fraction: A pilot study.
    J Heart Lung Transplant. 2016 Jul 27. pii: S1053-2498(16)30255.
    PubMed    


    June 2016
  83. BURGER CD
    Thyroid disease in pulmonary hypertension: Strange bedfellows?
    J Heart Lung Transplant. 2016 Jun 28. pii: S1053-2498(16)30189.
    PubMed    


  84. RICHTER MJ, Sommer N, Schermuly R, Grimminger B, et al
    The prognostic impact of thyroid function in pulmonary hypertension.
    J Heart Lung Transplant. 2016 Jun 3. pii: S1053-2498(16)30162.
    PubMed     Abstract available


    May 2016
  85. VITULO P, Stanziola A, Confalonieri M, Libertucci D, et al
    Sildenafil in severe pulmonary hypertension associated with chronic obstructive pulmonary disease: A randomized controlled multicenter clinical trial.
    J Heart Lung Transplant. 2016 May 7. pii: S1053-2498(16)30114.
    PubMed     Abstract available


    April 2016
  86. VAN DER FEEN DE, Dickinson MG, Bartelds B, Borgdorff MA, et al
    Egr-1 identifies neointimal remodeling and relates to progression in human pulmonary arterial hypertension.
    J Heart Lung Transplant. 2016;35:481-90.
    PubMed     Abstract available


    February 2016
  87. ROLDAN T, Landzberg MJ, Deicicchi DJ, Atay JK, et al
    Anticoagulation in patients with pulmonary arterial hypertension: An update on current knowledge.
    J Heart Lung Transplant. 2016;35:151-64.
    PubMed     Abstract available


    January 2016
  88. KANWAR MK, Thenappan T, Vachiery JL
    Update in treatment options in pulmonary hypertension.
    J Heart Lung Transplant. 2016 Jan 15. pii: S1053-2498(16)00067.
    PubMed     Abstract available


  89. D'ARMINI AM, Morsolini M, Mattiucci G, Grazioli V, et al
    Chronic thromboembolic pulmonary hypertension: From transplantation to distal pulmonary endarterectomy.
    J Heart Lung Transplant. 2016 Jan 6. pii: S1053-2498(16)00024.
    PubMed    


  90. KRISHNAMURTHY Y, Cooper LB, Lu D, Schroder JN, et al
    Trends and outcomes of patients with adult congenital heart disease and pulmonary hypertension listed for orthotopic heart transplantation in the United States.
    J Heart Lung Transplant. 2016 Jan 6. pii: S1053-2498(16)00012.
    PubMed     Abstract available


  91. GODINAS L, Amar D, Montani D, Lau EM, et al
    Lung capillary blood volume and membrane diffusion in precapillary pulmonary hypertension.
    J Heart Lung Transplant. 2016 Jan 6. pii: S1053-2498(16)00017.
    PubMed     Abstract available


    October 2015
  92. WIEDENROTH CB, Liebetrau C, Breithecker A, Guth S, et al
    Combined pulmonary endarterectomy and balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension.
    J Heart Lung Transplant. 2015 Oct 30. pii: S1053-2498(15)01491.
    PubMed     Abstract available


    September 2015
  93. BROCH K, Murbraech K, Ragnarsson A, Gude E, et al
    Echocardiographic evidence of right ventricular functional improvement after balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension.
    J Heart Lung Transplant. 2015 Sep 3. pii: S1053-2498(15)01382.
    PubMed     Abstract available


    March 2015
  94. CHIU JS, Zuckerman WA, Turner ME, Richmond ME, et al
    Balloon atrial septostomy in pulmonary arterial hypertension: effect on survival and associated outcomes.
    J Heart Lung Transplant. 2015;34:376-80.
    PubMed     Abstract available


  95. D'ARMINI AM, Ghofrani HA, Kim NH, Mayer E, et al
    Use of responder threshold criteria to evaluate the response to treatment in the phase III CHEST-1 study.
    J Heart Lung Transplant. 2015;34:348-55.
    PubMed     Abstract available


  96. LANGLEBEN D, Galie N, He J, Huang Y, et al
    Use of clinically relevant responder threshold criteria to evaluate the response to treatment in the phase III PATENT-1 study.
    J Heart Lung Transplant. 2015;34:338-47.
    PubMed     Abstract available


  97. PEZZUTO B, Badagliacca R, Poscia R, Ghio S, et al
    Circulating biomarkers in pulmonary arterial hypertension: update and future direction.
    J Heart Lung Transplant. 2015;34:282-305.
    PubMed     Abstract available


  98. DANDEL M, Knosalla C, Kemper D, Stein J, et al
    Assessment of right ventricular adaptability to loading conditions can improve the timing of listing to transplantation in patients with pulmonary arterial hypertension.
    J Heart Lung Transplant. 2015;34:319-28.
    PubMed     Abstract available


  99. ROACH EC, Park MM, Tang WH, Thomas JD, et al
    Impaired right ventricular-pulmonary vascular function in myeloproliferative neoplasms.
    J Heart Lung Transplant. 2015;34:390-4.
    PubMed     Abstract available


  100. HALLIDAY SJ, Hemnes AR, Robbins IM, Pugh ME, et al
    Prognostic value of acute vasodilator response in pulmonary arterial hypertension: beyond the "classic" responders.
    J Heart Lung Transplant. 2015;34:312-8.
    PubMed     Abstract available


  101. BADAGLIACCA R, Poscia R, Pezzuto B, Nocioni M, et al
    Right ventricular remodeling in idiopathic pulmonary arterial hypertension: adaptive versus maladaptive morphology.
    J Heart Lung Transplant. 2015;34:395-403.
    PubMed     Abstract available


  102. MARUYAMA H, Dewachter C, Belhaj A, Rondelet B, et al
    Endothelin-Bone morphogenetic protein type 2 receptor interaction induces pulmonary artery smooth muscle cell hyperplasia in pulmonary arterial hypertension.
    J Heart Lung Transplant. 2015;34:468-78.
    PubMed     Abstract available


  103. BENZA RL, Miller DP, Foreman AJ, Frost AE, et al
    Prognostic implications of serial risk score assessments in patients with pulmonary arterial hypertension: a Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL) analysis.
    J Heart Lung Transplant. 2015;34:356-61.
    PubMed     Abstract available


  104. FARBER HW, Miller DP, McGoon MD, Frost AE, et al
    Predicting outcomes in pulmonary arterial hypertension based on the 6-minute walk distance.
    J Heart Lung Transplant. 2015;34:362-8.
    PubMed     Abstract available


  105. BADAGLIACCA R, Poscia R, Pezzuto B, Papa S, et al
    Right ventricular dyssynchrony in idiopathic pulmonary arterial hypertension: determinants and impact on pump function.
    J Heart Lung Transplant. 2015;34:381-9.
    PubMed     Abstract available


  106. NAEIJE R, Guazzi M
    Waiting with a failing right heart.
    J Heart Lung Transplant. 2015;34:308-9.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: